Maria Carolina Mendes

Dr. Maria Carolina Mendes


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
LCLorena Pires da Cunha
Lorena Pires da Cunha
MSMarina Nogueira Silveira
Marina Nogueira Silveira
MMMaria Carolina Mendes
Maria Carolina Mendes
FCFelipe Osório Costa
Felipe Osório Costa
LMLigia Traldi Macedo
Ligia Traldi Macedo
JCJosé Carvalheira
José Carvalheira

1 June 2018 in Pharmacological Research
Verified
Journal Article
Closed access
FPFernanda Pace
Fernanda Pace
BCBruno Melo Carvalho
Bruno Melo Carvalho
TZTamires M. Zanotto
Tamires M. Zanotto
ASAndrey Santos
Andrey Santos
DGDioze Guadagnini
Dioze Guadagnini
MSMario Saad
Mario Saad

17 November 2022 in Nutrition
Verified
Journal Article
Closed access
KOKarina Hiromoto Oikawa
Karina Hiromoto Oikawa
FJFabiana Lascala Juliani
Fabiana Lascala Juliani
LCLarissa Ariel Oliveira Carrilho
Larissa Ariel Oliveira Carrilho
LPLara Pozzuto
Lara Pozzuto
DPDaniela Morais de Hollanda Padilha
Daniela Morais de Hollanda Padilha
JCJosé Carvalheira
José Carvalheira

27 October 2025 in Onco
Verified
Journal Article
Open access
PDF file
Ademar Dantas da Cunha JuniorAdemar Dantas da Cunha Junior
Ademar Dantas da Cunha Junior
LCLarissa Ariel Oliveira Carrilho
Larissa Ariel Oliveira Carrilho
PFPaulo Ricardo Santos Nunes Filho
Paulo Ricardo Santos Nunes Filho
LCLuca Cantini
Luca Cantini
LVLaura Vidal
Laura Vidal
KSKamal S. Saini
Kamal S. Saini
The inflammatory milieu surrounding tumors plays a pivotal yet paradoxical role in promoting carcinogenesis. Rather than simply acting as a host defense mechanism, chronic low-grade inflammation actively nurtures tumor development and supports hallmarks such as sustained proliferative signaling, apoptosis resistance, angiogenesis, and metastasis. Obesity, characterized by a chronic inflammatory state, exacerbates this tumor-promoting environment through metabolic imbalances like insulin resistance, hyperglycemia, and dyslipidemia. These conditions stimulate oncogenic signaling pathways and reshape the tumor microenvironment. Obesity-associated cytokines, altered adipokines, and insulin-related growth signals synergistically enhance processes such as epithelial-to-mesenchymal transition (EMT) and matrix remodeling. This review explores the mechanistic interplay between obesity-induced inflammation and insulin resistance in cancer progression, discusses the molecular pathways involved, and highlights emerging therapeutic approaches targeting these intersecting tumor promotion axes.

29 November 2016 in Nutrición Hospitalaria
Verified
Journal Article
Open access
LCLisiane Lopes da Conceição
Lisiane Lopes da Conceição
MDMariana De Moura Dias
Mariana De Moura Dias
MPMilene Pessoa
Milene Pessoa
GPGeórgia das Graças Pena
Geórgia das Graças Pena
MMMaria Carolina Mendes
Maria Carolina Mendes
MPMaria Do Carmo Gouveia Peluzio
Maria Do Carmo Gouveia Peluzio
Breast cancer is the second most common cancer in the world, and the most frequent cancer among women. Moreover, there are factors that influence the risk for breast cancer including the age, genetic and endocrine factors, and lifestyle. To evaluate the consumption of fatty acids; compare the fatty acids composition in the breast adipose tissue of women with breast cancer and benign breast disease as well as potential risk factors; and describe the genotypic frequency of the Pro12Ala PPARγ polymorphism. A hospital-based case-control study was conducted including incident cases (n= 38 breast cancer; n= 75 benign breast disease; n= 166 control). Lifestyle features, socioeconomic issues, dietary intake, anthropometry, and blood and tissue data were assessed. No differences were observed for fatty acids intake. Interestingly, lauric acid (p = 0.001), myristic acid (p = 0.036), stearic acid (p = 0.031), and total saturated fatty acids (SFAs) (p = 0.048) had lower concentrations in BC than in BBD women, while palmitoleic acid (p = 0.022), erucic acid (p = 0.002), total monounsaturated fatty acids (MUFAs) (p = 0.039) and oleic acid/stearic acid ratio (p = 0.015) increased. There was no significant association between PPARγ polymorphism and studied groups (p = 0.977). The age at first full pregnancy (p = 0.004) was significantly associated with the development BC, whereas BMI (p = 0.005); percentage of body fat (p = 0.024); physical activity (p = 0.036); and age at menarche (p = 0.008), at first full pregnancy (p < 0.001), and of first mammogram (p = 0.018) were significantly associated with the development of BBD. The results suggest a different fatty acids composition of breast adipose tissue, a biomarker of long-term dietary intake, particularly for SFAs, MUFA and 18: 1 n-9/18: 00 ratio. Our findings also show that are differences in the factors related to the development of BC and BBC.

1 August 2024 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
ASAmanda Cristina Ribeiro Silva
Amanda Cristina Ribeiro Silva
LALigia M Antunes-Correa
Ligia M Antunes-Correa
FJFabiana Lascala Juliani
Fabiana Lascala Juliani
LCLarissa Ariel Oliveira Carrilho
Larissa Ariel Oliveira Carrilho
FCFelipe Osório Costa
Felipe Osório Costa
JCJosé Carvalheira
José Carvalheira